Related Experiment Videos
Nonarteritic anterior ischemic optic neuropathy
Niraj Desai1, Milan R Patel, L Michael Prisant
1School of Medicine, Medical College of Georgia, Augusta, GA 30912, USA.
Journal of Clinical Hypertension (Greenwich, Conn.)
|February 22, 2005
Summary
Nonarteritic anterior ischemic optic neuropathy (NAION) causes sudden vision loss, often upon waking. While risk factors like hypertension exist, effective treatments are lacking, with many patients experiencing stable vision after diagnosis.
Area of Science:
- Ophthalmology
- Neurology
- Vascular Medicine
Background:
- Nonarteritic anterior ischemic optic neuropathy (NAION) is a frequent cause of acute, painless vision impairment.
- This condition typically affects middle-aged to elderly individuals, particularly Caucasian men and women.
- The contralateral eye is affected in fewer than 43% of cases within a 3-year period.
Purpose of the Study:
- To summarize the clinical presentation, risk factors, and prognosis of NAION.
- To highlight the lack of effective acute or preventative therapies for NAION.
- To provide insights into the long-term visual outcomes for affected individuals.
Main Methods:
- Literature review and synthesis of existing clinical data on NAION.
- Analysis of patient demographics and common presenting symptoms.
- Examination of identified risk factors and recurrence rates.
Main Results:
- NAION commonly presents upon waking and is characterized by sudden, painless vision loss.
- Key risk factors include hypertension, diabetes, nocturnal hypotension, and a congenital small cup-to-disk ratio.
- Approximately 57.3% of patients show no significant vision change or worsening after 6 months of follow-up.
Conclusions:
- Currently, no effective treatments exist for acute NAION or for preventing its recurrence.
- Understanding risk factors and prognosis is crucial for patient management and counseling.
- Long-term visual outcomes for NAION are variable, with a significant portion of patients maintaining their current visual status.